Inactive

This is a Justification & Approval (J&A) in accordance with FAR 6.302-1 Only one responsible source and no other supplies or services will satisfy agency requirements. This acquisition will allow BARD... This is a Justification & Approval (J&A) in accordance with FAR 6.302-1 Only one responsible source and no other supplies or services will satisfy agency requirements. This acquisition will allow BARDA to invest Project Bioshield funds for the procurement of a FDA licensed Zaire ebolavirus vaccine, ERVEBO; final drug product stored in vendor managed inventory (VMI) and; development of an updated manufacturing process.